Lipocine Inc.
For the period ended Dec 31, 2025. Filed Mar 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. FORM 10-K SUMMARY
None
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Lipocine Inc. | |
| (Registrant) | |
| Dated: March 10, 2026 | /s/ Mahesh V. Patel |
|---|---|
| Mahesh V. Patel, President and Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) | |
| Dated: March 10, 2026 | /s/ Krista Fogarty |
| Krista Fogarty, Corporate Controller (Principal Accounting Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Mahesh V. Patel | President and Chief Executive Officer (Principal Executive | March 10, 2026 |
| Mahesh V. Patel | Officer and Principal Financial Officer) | |
| /s/ Krista Fogarty | Corporate Controller (Principal Accounting Officer) | March 10, 2026 |
| Krista Fogarty | ||
| /s/ Jill M. Jene | Director | March 10, 2026 |
| Jill M. Jene | ||
| /s/ John Higuchi | Director | March 10, 2026 |
| John Higuchi | ||
| /s/ R. Dana Ono | Director | March 10, 2026 |
| R. Dana Ono | ||
| /s/ Spyros Papapetropoulos | Independent Lead Director and Chairman of the Board | March 10, 2026 |
| Spyros Papapetropoulos | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.